Skip to content

← All developments

North Carolina Medicaid Investigations Division · September 25, 2026 · Primary source

Attorney General Jeff Jackson Urges Eligible North Carolinians to Claim Compensation for Certain Generic Drug Purchases

Score 58PRIMARYenforcementState agencyNC

Summary

A court preliminarily approved a plan by a 48-state and territory coalition to distribute $96.5 million in settlements with generic drug manufacturers accused of conspiring to fix prices on certain generics between May 2009 and December 2019. Settling defendants include Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure. Additional complaints remain pending against Teva and 21 other manufacturers, a group of 26 corporate defendants on topical generics, and Novartis/Sandoz entities.

What this may mean

Eligible purchasers of covered generic drugs between 2009 and 2019 may file claims for restitution from the $96.5 million distribution fund. The multistate antitrust litigation against Teva and other large generic manufacturers remains active, with a trial scheduled for the third complaint focusing on 80 topical generics. The cases name individual senior executives as defendants alongside corporate entities, signaling personal liability exposure in the ongoing proceedings.

Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.

Related items